Tonix Pharmaceuticals Statistics Share Statistics Tonix Pharmaceuticals has 7.36M
shares outstanding. The number of shares has increased by 78.67%
in one year.
Shares Outstanding 7.36M Shares Change (YoY) 78.67% Shares Change (QoQ) 14.33% Owned by Institutions (%) 8.16% Shares Floating 7.35M Failed to Deliver (FTD) Shares 13,546 FTD / Avg. Volume 1.13%
Short Selling Information The latest short interest is 1.19M, so 16.15% of the outstanding
shares have been sold short.
Short Interest 1.19M Short % of Shares Out 16.15% Short % of Float 16.15% Short Ratio (days to cover) 1.5
Valuation Ratios The PE ratio is -0.57 and the forward
PE ratio is -7.64.
Tonix Pharmaceuticals's PEG ratio is
0.01.
PE Ratio -0.57 Forward PE -7.64 PS Ratio 7.4 Forward PS 4 PB Ratio 0.53 P/FCF Ratio -1.22 PEG Ratio 0.01
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Tonix Pharmaceuticals.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 6.5,
with a Debt / Equity ratio of 0.06.
Current Ratio 6.5 Quick Ratio 6.04 Debt / Equity 0.06 Debt / EBITDA -0.11 Debt / FCF -0.13 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $124.62K Profits Per Employee $-1.61M Employee Count 81 Asset Turnover 0.06 Inventory Turnover 0.92
Taxes Income Tax -1.17M Effective Tax Rate 0.9%
Stock Price Statistics The stock price has increased by -12.27% in the
last 52 weeks. The beta is 1.72, so Tonix Pharmaceuticals's
price volatility has been higher than the market average.
Beta 1.72 52-Week Price Change -12.27% 50-Day Moving Average 40 200-Day Moving Average 25.79 Relative Strength Index (RSI) 57.36 Average Volume (20 Days) 1,201,703
Income Statement In the last 12 months, Tonix Pharmaceuticals had revenue of 10.09M
and earned -130.04M
in profits. Earnings per share was -3504.
Revenue 10.09M Gross Profit 2.33M Operating Income -77.74M Net Income -130.04M EBITDA -74.94M EBIT -75.7M Earnings Per Share (EPS) -3504
Full Income Statement Balance Sheet The company has 98.78M in cash and 8.12M in
debt, giving a net cash position of 90.66M.
Cash & Cash Equivalents 98.78M Total Debt 8.12M Net Cash 90.66M Retained Earnings -730.69M Total Assets 192.87M Working Capital 137.43M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -60.92M
and capital expenditures -120K, giving a free cash flow of -61.05M.
Operating Cash Flow -60.92M Capital Expenditures -120K Free Cash Flow -61.05M FCF Per Share -26.97
Full Cash Flow Statement Margins Gross margin is 23.07%, with operating and profit margins of -770.2% and -1288.25%.
Gross Margin 23.07% Operating Margin -770.2% Pretax Margin -1288.25% Profit Margin -1288.25% EBITDA Margin -742.39% EBIT Margin -770.2% FCF Margin -604.77%
Dividends & Yields TNXP does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for TNXP is $70,
which is 55.8% higher than the current price. The consensus rating is "Buy".
Price Target $70 Price Target Difference 55.8% Analyst Consensus Buy Analyst Count 1
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Feb 5, 2025. It was a
backward
split with a ratio of 1:100.
Last Split Date Feb 5, 2025 Split Type backward Split Ratio 1:100
Scores Altman Z-Score 10.69 Piotroski F-Score 5
